2seventy bio, Inc.
TSVT
$4.99
$0.010.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 65.65% | 86.13% | 159.11% | -12.02% | -145.53% |
| Total Depreciation and Amortization | -45.38% | -39.97% | -25.11% | -6.56% | 30.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -61.19% | -92.10% | -837.81% | -21.77% | -61.47% |
| Change in Net Operating Assets | 154.54% | -113.62% | -405.57% | 115.65% | 62.93% |
| Cash from Operations | 85.10% | 51.17% | 29.15% | 14.69% | -33.62% |
| Capital Expenditure | 100.00% | 98.76% | 98.46% | 89.93% | 90.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -55.09% | -320.57% | 158.28% | -56.23% | 1,758.81% |
| Cash from Investing | -54.08% | -358.48% | 220.90% | -51.26% | 663.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.81% | -- | -- | -99.70% | 9.05% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.81% | 169.33% | -118.75% | -99.70% | 9.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 181.01% | -838.91% | 156.74% | -116.01% | 72.34% |